Viatris Inc. Common Stock

VTRSNASDAQ • USD
17.48 USD
↘ 0.06 (0.33%)🟢LIVE (AS OF 11:14 AM EDT)
🟢Market: OPEN

VTRS is currently priced at $17.48. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest VTRS is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 12, 2026.

Open?$17.66
High?$17.78
Low?$17.34
Prev. Close?$17.54
Volume?1.7M
Avg. Volume?8.9M
VWAP?$17.47
Rel. Volume?0.19x
Bid / Ask
Bid?$17.55 × 2.2K
Ask?$17.56 × 1.3K
Spread?$0.01
Midpoint?$17.56
Valuation & Ratios
Market Cap?20.1B
Shares Out?1.1B
Float?1.1B
Float %?99.7%
P/E Ratio?N/A
P/B Ratio?1.41
EPS?-$0.36
Dividend?0.00%
Ex-Dividend?N/A
RelatedPFE
News
Profile
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
Employees
30.0K
Market Cap
20.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1973-02-23
Address
1000 MYLAN BOULEVARD
CANONSBURG, PA 15317
Phone: (724) 514-1465
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
13
Momentum?
14
Short Sent.?
69
Piotroski F-Score?5/9Mixed
Altman Z-Score?1.11Distress
Confidence?67%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.67%Low
Short Interest?42.0M
Days to Cover?4.2
Free Float1.1B
Avg Daily Volume10.1M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.58Adequate
Quick Ratio?0.96Weak
Cash Ratio?0.14Low
Debt/Equity?0.94Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
89
1.41CHEAP▾
P/S?
Peers
100
S&P
81
1.37CHEAP▾
P/FCF?
Peers
100
S&P
88
10.3CHEAP▾
EV/EBITDA?
Peers
50
S&P
73
11.3CHEAP▾
EV/Sales?
Peers
100
S&P
72
2.21CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
13
-2.9%WEAK▾
ROA?
Peers
50
S&P
3
-1.2%WEAK▾
Cash Flow & Enterprise
FCF?$2.0B
Enterprise Value?$32.6B
Fundamentals ratios updated end of day